Concepedia

Bas Weenink

BW

Statistics

Publications

5

Citations

277

H-Index

5

Active since

2015

Affiliations

Erasmus MC Cancer Institute(Current)

Erasmus MC

Bas Weenink is an author at Erasmus MC Cancer Institute specializing in oncology, immunology, and cancer immunology.

ORCID

Publications per year

2015–2020

5

Publications

5

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives

Bas Weenink, Pim J. French, Peter A.E. Sillevis Smitt et al. · Cancers · 2020 · 102 citations · Full text

, , +17

PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients

Kaspar Draaisma, Maarten M.J. Wijnenga, Bas Weenink et al. · Acta Neuropathologica Communications · 2015 · 67 citations · Full text

, , +17

Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens

Bas Weenink, Kaspar Draaisma, Han Zi Ooi et al. · Scientific Reports · 2019 · 56 citations · Full text

, , +17

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial

Ya Gao, Bas Weenink, Martin J. van den Bent et al. · European Journal of Cancer · 2018 · 39 citations

, , +15

Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients

Bas Weenink, Mandy van Brakel, Rebecca Wijers et al. · Journal of Neuro-Oncology · 2019 · 13 citations · Full text

, , +17

1–5 of 5